Therefore, CEACAM1 function may represent a potential target in order to delay unfavorable age‐dependent vascular alterations, thereby preventing the onset of transition from physiological aging into angiopathies with their secondary diseases such as myocardial infarction and stroke. This evidence concerns the gene CEACAM1 and Stroke.